Xeris Biopharma President and COO Kevin McCulloch Reports Sale of 15,000 Common Shares for $153,487.50

PUBT · 2d ago
Xeris Biopharma President and COO Kevin McCulloch Reports Sale of 15,000 Common Shares for $153,487.50
  • Xeris Biopharma President and Chief Operating Officer Kevin McCulloch sold 15,000 common shares on Nov. 2, 2026, at $10.2325 per share.
  • Following the sale, McCulloch directly held 1,584,208 common shares, with another 25,000 shares held indirectly through his spouse.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001867096-26-000107), on November 04, 2026, and is solely responsible for the information contained therein.